LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fiserv, Inc. ("Fiserv" or "the Company") (NYSE: FI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 24, 2024 and July 22, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before September 22, 2025.

LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 9, 2024, and July 10, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before September 15, 2025.

LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lockheed Martin Corporation ("Lockheed Martin" or "the Company") (NYSE: LMT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 23, 2024 and July 21, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before September 26, 2025.

There is a disconnect between Lyft's fundamentals and its current market price. The rideshare industry provides tailwind, and the company's recent earnings reports provide bright spots not recognized by the market. LYFT's domestic partnership and global expansion reflect proper investment decisions by management.

HAMILTON, Bermuda, 18 August 2025 – Reference is made to the joint stock exchange announcement on 28 May 2025 by Golden Ocean Group Limited (NASDAQ: GOGL & Euronext Oslo Børs: GOGL) ("Golden Ocean") and CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) ("CMB.TECH") where it was announced that Golden Ocean would be merging with and into CMB.TECH Bermuda Ltd., a wholly-owned subsidiary of CMB.TECH, with CMB.TECH Bermuda as the surviving company, with CMB.TECH as the issuer of the merger consideration shares (the "Merger").

SoundHound AI delivered strong Q2 results, beating revenue and earnings estimates, driven by robust enterprise adoption and impressive 207% year-over-year top-line growth. Despite raising FY 2025 revenue guidance, SoundHound AI remains unprofitable, with widening losses and no near-term path to profitability. Valuation is high based off of revenue, with shares trading at a high price-to-revenue ratio compared to hardware AI companies like Nvidia and AMD, reflecting fully priced-in AI optimism.

LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the federal securities laws. Shareholders who purchased the Company's securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 25, 2025.

Hangzhou-based Unitree Robotics brought the spotlight-grabbing machines at a robots competition in Beijing, boosting its reputation as a national champion for China's ambitions in developing AI and humanoids. Bloomberg's Annabelle Droulers reports.

Grupo Aeroportuario del Centro Norte remains my top pick among Mexican airport operators, thanks to its strong business mix and exposure to industrial hubs like Monterrey. The reshoring trend and Mexico's manufacturing boom, especially in Monterrey, are fueling robust traffic and non-aeronautical revenue growth for OMAB. Despite a 40% stock price run-up, the company is still reasonably valued, with solid EBITDA growth and a compelling dividend policy supporting long-term returns.

Upstart delivered a strong Q2, beating earnings and revenue estimates, driven by robust demand for personal loans and improved conversion rates. The Fintech achieved GAAP profitability in Q2'25, signaling an inflection point and validating its AI-driven lending platform's scalability. Upstart's shares dropped 19%, following the earnings report, highlighting an engagement opportunity for investors.

SAN DIEGO , Aug. 18, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Charter Communications, Inc. (NASDAQ: CHTR) securities, purchased call options on Charter common stock, or sold put options on Charter common stock, between July 26, 2024 and July 24, 2025. Charter is a leading broadband, or high-speed Internet, connectivity company and cable operator.

Kennametal has faced revenue, profit, and cash flow declines due to end-market weakness, underperforming the S&P 500 since my last bullish rating. Despite near-term pain and recession risks, management's aggressive cost-cutting—including plant closures—should yield significant savings and improve future profitability. Relative to peers, KMT shares are extremely cheap on multiple valuation metrics, even when factoring in further expected earnings weakness.

SAN DIEGO , Aug. 18, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Unicycive Therapeutics, Inc. (NASDAQ: UNCY) securities between March 29, 2024 and June 27, 2025. Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

BOSTON--(BUSINESS WIRE)--PureTech Health: Notice of Half-Yearly Results.

REITs are deeply out of favor, but this has created a rare valuation gap vs. equities, historically followed by strong outperformance. Realty Income has continued to deliver double-digit operational returns. With interest rate cuts likely ahead, the environment is set to become much more favorable for REITs like O.

Integra Resources is a growing US-focused gold producer, leveraging strong cash flow from Florida Canyon and rising gold prices to fund expansion and development. Record gold prices have driven robust Q2 2025 financials, enabling reinvestment in Florida Canyon, DeLamar, and Nevada North projects for long-term growth. The company's healthy balance sheet, disciplined cost control, and significant resource base support its ambition to become a leading US gold producer.

Persisting supply chain disruptions have resulted in delayed engine parts delivery, a few on-the-wing engines being serviced, high turnaround time, and even higher demand for spare engines. For the last quarter, Willis has recorded a record high revenue of $195 million and a 30% margin realization from gains on engine sales, reflecting high demand and residual value. With all the tailwinds listed, WLFC seemed to be priced fairly by the market, and the margin profile is concerning, given the increasing operational and interest expenses.

PRESS RELEASE Two VictORION studies will highlight Leqvio's impact on patient quality of life, and as a cholesterol lowering monotherapy Lp(a)FRONTIERS APHERESIS study will assess effect of pelacarsen on reducing need for lipoprotein apheresis – a cholesterol removal procedure similar to dialysis PARACHUTE-HF study will highlight the efficacy and safety of Entresto to treat heart failure with reduced ejection fraction due to chronic Chagas disease Additional presentations will assess the safety of new pipeline asset abelacimab in atrial fibrillation Basel, August 18, 2025 – Novartis will present data from 19 abstracts across its cardiovascular portfolio at the 2025 European Society …

SGOV is designed for low-risk, highly liquid cash management, offering slightly higher returns than a bank account with minimal credit and interest rate risk. It's not a tool for long-term capital growth, but ideal for parking emergency funds or short-term savings within a balanced portfolio. SGOV's structure ensures easy access, negligible spread, and virtually no risk of a redemption cascade, making it reliable in both normal and stressed markets.

Saint Herblain (France), August 18, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that Health Canada has granted marketing authorization for its single-dose vaccine, IXCHIQ®, for the prevention of disease caused by the chikungunya virus in individuals aged 12 years and older. This announcement adds to the adult marketing authorization already received in Canada 1 and complements the adolescent label extension received in Europe in April 20252.